Article Information
History
- April 4, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- Krufinta Bun1,
- Benedict Mode2,
- Melinda Susapu3,
- Catherine Bjerum1,
- Michael Payne1,
- Daniel Tisch1,
- Makoto Sekihara5,
- Emanuele Giorgi6,
- Gary J. Weil8,
- Peter U Fischer8,
- Leanne Robinson7,
- Moses Laman4 and
- Christopher L. King1,9,*
- 1Center for Global Health and Disease, Department of Pathology, Case Western Reserve University, Cleveland OH USA
- 2Provincial Health Department, East New Britain Province, Papua New Guinea
- 4Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea
- 3Papua New Guinea Department of Health, Port Moresby, Papua New Guinea
- 5Japan International Cooperation Agency (JICA)
- 6Centre for Health Informatics, Computing and Statistics, Lancaster University, Lancaster, UK
- 7Burnet Institute, Melbourne, AU,
- 8Infectious Diseases Division, Department of Medicine, Washington University, St. Louis MO, USA,
- 9Veterans Affairs Medical Center, Cleveland, OH
- ↵*Christopher L. King, Corresponding author cxk21{at}case.edu
Posted April 04, 2024.
Alternative Approaches for Monitoring and Evaluation of Lymphatic Filariasis Following Mass Drug Treatment with Ivermectin, Diethylcarbamazine and Albendazole in East New Britain Province, Papua New Guinea
